Host Genetic Susceptibility to Avian Influenza A/H5N1

计划入组 500 人 · 首次发布于 2010 年 2 月 24 日

Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart

计划入组 312 人 · 首次发布于 2025 年 12 月 10 日

China Case Control Avian Influenza

计划入组 100 人 · 首次发布于 2007 年 1 月 30 日

H5N1 avian influenza vaccine

H5N1 avian influenza vaccine (PowderMed)

H7N9 avian influenza A vaccine

Research Institute of Influenza

Russia

Sernova Corp

Canada

A&A SMALL CHANGES HANDYPEOPLE

United States

Cocrystal Pharma's CC-42344 Shows Activity Against H5N1 Avian Influenza in Preclinical Studies

mRNA Vaccines Show Promise as H5N1 Avian Influenza Cases Rise in US Cattle and Humans

Cocrystal Pharma's CC-42344 Shows 1,000-Fold Greater Potency Than Tamiflu Against H5N1 Avian Influenza